SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001105806-19-000003
Filing Date
2019-02-13
Accepted
2019-02-13 16:42:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 azrx.txt SC 13G/A 4708
  Complete submission text file 0001105806-19-000003.txt   6010
Mailing Address 467 CPW NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SC 13G/A

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Subject) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-89966 | Film No.: 19598072
SIC: 2834 Pharmaceutical Preparations